AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 285: R470-R478, 2003. First published April 24, 2003; doi:10.1152/ajpregu.00732.2002
0363-6119/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/2/R470    most recent
00732.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (52)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vrang, N.
Right arrow Articles by Berthoud, H.-R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vrang, N.
Right arrow Articles by Berthoud, H.-R.

APPETITE, OBESITY AND METABOLISM

Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons

Niels Vrang,1 Curtis B. Phifer,2 Michele M. Corkern,3 and Hans-Rudolf Berthoud3

1Rheoscience, 2610 Rødovre, Denmark; 2Louisiana Scholars'College, Northwestern State University, Natchitoches; and 3Neurobiology of Nutrition Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana

Submitted 2 December 2002 ; accepted in final form 16 April 2003


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
A group of neurons in the caudal nucleus of the solitary tract (NTS) processes preproglucagon to glucagon-like peptides (GLP)-1 and -2, peptides that inhibit food intake when administered intracerebroventricularly. The GLP-1/2-containing neural pathways have been suggested to play a role in taste aversion and nausea because LiCl activates these neurons, and LiCl-induced suppression of food intake can be blocked by the GLP-1 receptor antagonist exendin-9. As many gastrointestinal signals related to both satiety and nausea/illness travel via the vagus nerve to the caudal medulla, the present study assessed the capacity of different types of gastric distension (a purely mechanical stimulus) to activate GLP-1 neurons in the caudal NTS. Gastric balloon distension (1.4 ml/min first 5 min, 0.4 ml/min next 5 min, 9 ml total, held for 60 min) in nonanesthetized, freely moving rats produced 12- and 17-fold increases in c-Fos-expressing NTS neurons when distension was mainly in the fundus or corpus, respectively. Fundus and corpus distension increased the percentage of c-Fos-activated GLP-1 neurons to 21 ± 9% and 32 ± 5% compared with 1 ± 1% with sham distension (P < 0.01). Thus gastric distension that may be considered within the physiological range activates GLP-1/2-containing neurons, suggesting some role in normal satiety. The results support the view that the medullary GLP system is involved in appetite control and is activated by stimuli within the behavioral continuum, ranging from satiety to nausea.

preproglucagon; fundus; corpus


PREPROGLUCAGON GENE EXPRESSION is limited to {alpha}-cells in the pancreas, L cells in the gut, and neurons in the brain stem nucleus of the solitary tract (NTS) (15). Whereas posttranslational processing of proglucagon in the pancreas leads to the formation of glucagon and the major proglucagon fragment, proteolytic cleavage in the L cells of the gut and in the NTS yields the peptides glicentin, oxyntomodulin, glucagon-like peptide (GLP)-1, and GLP-2 (2, 11, 18). GLP-1 is secreted from L cells in response to a meal (17) and plays an important role as an incretin (12, 23). Additionally, peripheral GLP-1 has been shown to delay gastric emptying (30), and several groups have demonstrated appetite-suppressive effects of peripherally administered GLP-1 or GLP-1 agonists in humans (7, 10, 47) and rats (19). L cell-derived GLP-2 was recently recognized to function as an intestinal epithelial growth factor (5).

In the central nervous system, GLP-1 and GLP-2 function as neurotransmitters in a discrete population of neurons located in the caudal part of the NTS. Immunohistochemical and neuroanatomical tract tracing methods have demonstrated dense GLP-1-containing projections to several hypothalamic areas involved in the regulation of food and water intake (14, 18, 22, 28), areas that also contain GLP-1 and GLP-2 receptors (22, 39). Consistent with these observations, intracerebroventricular administration of GLP-1 inhibits food and water intake in rats (38, 40, 44). Recently, GLP-2 (39) and oxyntomodulin (4) were shown to suppress food intake in rats when injected intracerebroventricularly. The precise function of GLP-1 in central appetite-regulating pathways has been intensely investigated over the last couple of years. Reports of GLP-1-induced taste aversion coupled with GLP-1-induced activation of central oxytocin-containing neurocircuits has led several groups to investigate the role of GLP-1 in aversive stimuli. Indeed, an increasing body of evidence points to a role of GLP-1 neurons in mediating anorexia associated with a variety of interoceptive stressors. Several chemical stimuli known to potently suppress food intake and produce conditioned taste aversion, such as intraperitoneal injections of LiCl or LPS as well as peripheral injections of cholecystokinin have been shown to induce c-Fos expression in brain stem GLP-1-immunoreactive (ir) neurons (28). Also, LiCl-induced anorexia and taste aversion can be significantly blunted by prior injection of GLP-1 receptor antagonists, further supporting a functional role of endogenous GLP-1-containing neural pathways as mediators of LiCl-induced aversive behavior (27, 35). Although these findings point to a role of GLP-1 neurons as important mediators of interoceptive stressors, the neurons are in an excellent position to respond also to more physiologically relevant gastrointestinal satiety signals in the course of a normal meal.

In the present experiment we sought to investigate the effect of a purely mechanical gastrointestinal stimulus (gastric balloon distension) on the activation of GLP-1/2 and catecholamine-synthesizing neurons in the caudal part of the NTS by the use of triple labeling immunohistochemistry for GLP-2, tyrosine hydroxylase (TH), and the immediate early gene c-Fos. The experiment was carried out in freely moving rats, and the rate and magnitude of distension were designed to mimic an average physiological meal in moderately food-deprived rats.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Animals and surgical procedures. Eighteen male Sprague-Dawley rats (250–300 g) were obtained from Harlan Industries (Indianapolis, IN). The rats were housed individually in wire-mesh cages and maintained under standard laboratory conditions (23 ± 3°C, 12:12-h light-dark cycle with lights on at 0700). Food (Purina chow 5001) and water were available ad libitum, except during 15- to 17-h deprivation periods before infusion experiments. All experiments were carried out according to the guidelines of the local Animal Care and Use Committee and the National Institutes of Health. With rats under deep anesthesia (ketamine-xylazine-acepromazine, 80:4:1.6 mg/kg sc) and administration of atropine (0.5 mg/kg ip), a small stab wound was placed into the fundus of the stomach close to the glandular stomach at the greater curvature. The inner flange of a cylindrical stainless steel fistula was inserted through the hole and secured with a purse-string suture. The other end of the fistula was exteriorized through the peritoneal wall and skin, with a circular piece of Marlex mesh cemented to the core of the fistula, forming a tight connection with the inside of the peritoneal wall. The fistula was closed with a worm screw, using petroleum jelly as a sealant.

Distension experiments and perfusion. In several sessions, animals were adapted in special acrylic test cages to rinsing the stomach with warm saline and inserting a small latex balloon. On the experimental day, after 15–17 h of overnight food deprivation, the empty balloon was inserted through the fistula and placed in the proximal stomach. After animals rested for 1 h, the balloon was inflated with 9 ml of warm saline at a rate of 0.9 ml/min, and inflation was maintained for an additional 50 min. In control animals, the balloon was inserted but not inflated, and the external tubing to the balloon was cut to avoid mucosal stimulation by the empty balloon. One animal was excluded from the experiment because of a leaky balloon. One hour after the start of distension, animals were killed with an overdose of pentobarbital sodium and perfused transcardially with 150 ml of heparinized saline (20 U/ml) followed by 400 ml of cold 4% phosphate-buffered paraformaldehyde (pH 7.4) containing 0.3% picric acid. After the perfusion, the exact location of the inflated balloon within the stomach was determined by estimating the percentage of the total volume of the balloon in the fundus, corpus, and antrum, with the limiting ridge delineating the border between fundus and corpus. On the basis of this evaluation, two groups were formed: one group (n = 6; 1 animal excluded due to a leaky balloon) with >70% of the total balloon volume in the fundus, and one group (n = 7) with >60% of the balloon volume in the corpus and antrum. Brains were removed and postfixed in the same fixative at 4°C overnight. A block containing the caudal brain stem was placed overnight in 4% paraformaldehyde containing 25% sucrose and frozen, and coronal sections were cut in a cryostat in five series at 30-µm intervals. The sections were stored at -20°C in cryoprotectant solution (50% PBS, 20% glycerol, 30% ethylene glycol) for later processing.

Immunohistochemisty. One series of sections from each rat was subjected to a triple immunohistochemical procedure to visualize c-Fos, GLP-2, and TH simultaneously. Because both the GLP-2 and TH antibodies were mouse monoclonal, it was necessary to visualize these antigens by the use of tyramide amplification technique as has been described by us and others previously (24, 36). Tyramide amplification allows the use of one of the primary antibodies in dilutions [monoclonal GLP-2 antibody (F1221) diluted 1:1,600] that are undetectable by a direct technique (fluorescent secondary antibodies). Therefore, once the tyramide signal amplification reaction has been terminated, the other primary mouse antibody can be used in a concentration suitable for direct visualization. This, combined with the fact that brain stem GLP-1 (which is costored with GLP-2)-immunopositive neurons are separate from TH-positive neurons (18), made the use of two primary mouse antibodies possible. All reactions were carried out on free-floating sections. First, sections were rinsed 3 x 10 min in phosphate-buffered saline containing 50 mM KCl (KPBS, pH 7.4). Next, sections were transferred to a 10 mM sodium citrate solution (pH 6.0) and heated in a water bath at 85°C for 90 min. Others (13) have described this method of unmasking antigens in formaldehyde and paraffin-embedded tissue in detail. Sections were allowed to cool for 20 min in the citrate buffer, then rinsed 2 x 5 min in KPBS followed by a 10-min incubation in 1 ml of 1% H2O2 in KPBS. After a 20-min incubation in 5% swine serum in KPBS containing 0.3% Triton X-100 (TX) and 1.0% BSA, the sections were incubated overnight at 4°C in rabbit anti-c-Fos [1:100,000; code 94012–4; (46)] and mouse anti-GLP-2 antibodies (1:1,600, code F1221, generously provided by Dr. Jes T. Clausen, NovoNordisk A/S) diluted in KPBS containing 0.3% TX and 1.0% BSA. The next day, the sections were washed for 3 x 10 min in KPBS with 0.1% TX (KPBS-T) before incubation for 60 min at room temperature in a biotinylated donkey anti-rabbit antibody (Jackson Immunoresearch Lab) diluted 1:200 in KPBS-T. After three rinses for 10 min in KPBS-T followed by 60 min in ABC-streptavidin-horseradish peroxidase (Vector Elite Kit; Vector Laboratories, Burlingame, CA) the sections were washed 3 x 10 min in KPBS-T. Sections were then reacted for 12 min in biotinylated tyramide [biotinylated according to the procedure described in Ref. 1 using tyramine-HCl (Sigma Aldrich) and sulfosuccinimidyl-6-(biotinimide) hexanoate (NHS-LC-biotin; Pierce, Rockford, IL)] diluted 1:100 in KPBS-T containing 0.005% H2O2. After the tyramide amplification, sections were rinsed 3 x 5 min in KPBS-T and incubated for 60 min in streptavidin-Alexa 546 (Molecular Probes, Eugene, OR) diluted 1:200 in KPBS-T. Three rinses for 5 min in KPBS-T preceded 10 min in KPBS-T + 1% H2O2, the latter to destroy remaining horseradish peroxidase activity. After 3 x 5 min in KPBS-T the sections were incubated for 60 min in a horseradish peroxidase coupled donkey anti-mouse antibody (to label the mouse GLP-2 antibody), rinsed 3 x 5 min in KPBS-T, and subsequently incubated for 12 min in FITC-labeled tyramine diluted 1:100 in KPBS-T + 0.005% H2O2 [labeled using tyramine-HCL (Sigma Aldrich) and HS-LCFITC (fluorescein, Pierce) in a procedure similar to the biotinylated tyramine described above]. After this detection reaction, sections were rinsed 3 x 5 min in KPBS-T and incubated overnight at 4°C with a mouse monoclonal antibody to tyrosine hydroxylase (Sigma Aldrich, batch 020K4836) diluted 1:4,000 in KPBS + 0.3% TX + 1.0% BSA. On the third day, sections were washed 3 x 10 min in KPBS-T, incubated for 60 min in a Cy5-coupled donkey anti-mouse antibody (Jackson Immunoresearch Laboratories) diluted 1:200 in KPBS-T, then rinsed 2 x 10 min in KPBS-T and finally 10 min in distilled water before being mounted in a 0.5% gelatine solution. Slides were dehydrated through a graded series of ethanol dilutions (30%, 60%, 80%, 96%, 99%, and xylene) before being placed under a coverslip in Pertex.

Image acquisition and estimation of cell counts. A Zeiss confocal laser-scanning microscope (LSM 510) equipped with two HeNe lasers and one argon laser was used to visualize the three fluorophores simultaneously. Images used for the semiquantitative analysis were acquired using a x20 objective and a pinhole size that yielded optical sections ~6 µm thick. One optical section was acquired per section where all three antigens were optimally stained. Images were acquired from all sections containing the NTS caudal to the rostral tip of the area postrema (10–12 sections per animal, each section spaced 150 µm). In the commissural part of the NTS, one image covered the entire NTS. At more rostral levels, two images, covering each side of the NTS, were acquired. Cells [c-Fos-ir nuclei, GLP-2-ir cells, TH-ir cells] were counted automatically using Image Pro Plus 4.6. The program was set to count the number of c-Fos-, GLP-2-, and TH-positive cells based on size and color/intensity. The number of GLP-2- and TH-positive cells colocalizing c-Fos was scored manually in the same session by an observer blinded to the treatment. To look for possible regional differences, the analyzed NTS sections were divided into rostral sections (sections of the NTS underlying the area postrema), midsections (caudal to the area postrema, rostral to the pyramidal decussation), and caudal sections (at the level of the pyramidal decussation). The fraction (percentage) of GLP-2-ir cells containing c-Fos for the NTS as a whole was calculated as (total number of GLP-2-positive cells with c-Fos)/(total number of GLP-2-positive cells)x100. The fraction of GLP-2/TH-ir cells containing c-Fos for the three rostrocaudal levels of the NTS was calculated in a similar fashion. TH-, GLP-2-, and c-Fos-ir cell counts are expressed as number of cells per section rather than total number of cells to adjust for differences in numbers of sections (varied from 10–12 sections per animal).

Production of photomicrographs. Tricolor images acquired using the LSM 510 Zeiss laser confocal microscope were enhanced for brightness and contrast in Adobe Photoshop 7.0 and combined into plates using Adobe Illustrator 10.0 (Fig. 3). Adobe Illustrator plates (plates 70 to 73) from the atlas by Swanson (37) were used to generate the map of labeled cells in Fig. 4.



View larger version (36K):
[in this window]
[in a new window]
 
Fig. 3. Panel of confocal images showing the distribution of TH (blue)-, GLP-2 (green)-, and c-Fos (red)-ir in a no-distention control rat (PG-58; A, C, E) and in a corpus-distended rat (PG-51; B, D, F–H). Arrows point to cells double stained for c-Fos and GLP-2. G and H show GLP2/c-Fos colocalization at high magnifications. In G, the thickness of the optical slice is ~2 µm (in H, 1 µm). Scale bars: A-F, 50 µm; G and H, 10 µm.

 


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4. c-Fos ({bullet})-, TH ({square})-, and GLP-2-positive ({star}) neurons are plotted in single 30-µm tissue sections through the caudal NTS. GLP-2-ir and TH-ir neurons containing c-Fos are shown as and , respectively. Distribution of cells in 1 control animal and in 1 corpus-distended rat (PG44b) is shown. Drawings are arranged from rostral (top) to caudal (bottom) and are from the atlas by Swanson (plates 70 to 73) (37).

 

Statistics. Statistical evaluation of the cell counts and percentage colocalization used one-way ANOVA followed by Fisher's post hoc analysis. Results are expressed as means ± SE from groups of four to six rats. P values <0.05 were considered significant.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
The distribution of GLP-2-ir cells corresponds to the distribution of GLP-1-ir cells reported previously (14, 18, 22, 28). Notably, double-labeling experiments between a rabbit anti-GLP-1 specific antibody [used previously in the rat (18)] and the mouse anti-GLP-2 antibody used in the present experiments showed 100% colocalization (data not shown). Gastric distension induced a pattern of c-Fos expression in the dorsal vagal complex identical to that reported previously (3, 45). In the NTS, the number of c-Fos-positive nuclei increased dramatically on gastric distension. The average number of immunopositive cells per section is given in Table 1. Whereas the same number of TH- and GLP-2-ir cells was found throughout the caudal NTS (except TH-ir cells at midlevels) in both control and distended rats, significantly higher numbers of c-Fos-ir cells were found at all levels (Table 1 and Fig. 3). Counting of double-labeled cells (TH with c-Fos and GLP-2 with c-Fos) revealed a significant increase in the fraction of GLP-2-ir cells containing c-Fos after both fundus and corpus distension (percent GLP-2 with c-Fos: no-distension control 1.1 ± 1.1; fundus distension 21.7 ± 9.4; corpus distension 32.1 ± 5.3; P < 0.05 fundus and corpus distension vs. control). Although corpus-distended rats had higher numbers of GLP-2 neurons with c-Fos than fundus-distended rats, this difference failed to reach statistical significance due to the presence of "outliers" in each group. The tendency for rats with mainly corpus distension to have higher degrees of GLP-neuron activation is more clearly seen when individual counts are examined (Table 2). The highest degree of c-Fos expression in GLP-2 neurons was observed in the caudal part of the NTS and declined rostrally (Fig. 2). Because the highest numbers of GLP-2-ir cells were located in the midregion, the cell counts most closely match the total counts (compare Fig. 1 and Fig. 2). Only a few TH-ir cells were found to colocalize c-Fos (Fig. 2B). Due to the presence of one rat in the control group with an exceptionally high degree of TH/c-Fos colocalization (see rat PG-46, Table 2), no statistically significant degree of c-Fos induction in TH neurons was found. However, the fraction of TH neurons activated in the two gastric distension groups corresponds to our previous findings (45). Figure 3 contains examples of tricolor confocal images from one no-distension control animal (Fig. 3, A, C, and E) and from one corpus-distended rat (B, D, F, G, and H) showing double-labeled neurons. Distribution maps of immunoreactive neurons within the dorsal vagal complex are shown in Fig. 4 for one no-distention control and one corpus-distended rat.


View this table:
[in this window]
[in a new window]
 
Table 1. Number of c-Fos-, GLP-2-, and TH-ir cells per section for the caudal NTS as a whole (Total) and for the 3 subareas as defined in MATERIALS AND METHODS

 

View this table:
[in this window]
[in a new window]
 
Table 2. Number of TH and GLP-ir cells containing c-Fos (expressed as % total TH/GLP-ir cells) from individual animals

 


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2. Percentage of GLP-2-ir (A) and tyrosine hydroxylase (TH)-ir cells (B) containing c-Fos at 3 different rostrocaudal levels of the caudal nucleus of the solitary tract (NTS; caudal, the commissural part of the NTS; rostral, the subpostremal NTS; mid, sections in between). Open bars, control groups; shaded, fundus; filled, corpus-distended groups. Although corpus distension tended to increase the number of TH cells containing c-Fos at all levels examined, this induction failed to reach statistical significance. *Significant difference from control group as determined by 1-way ANOVA followed by Fisher's post hoc test.

 


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1. Percentage of glucagon-like peptide-2 (GLP-2)-immunoreactive (ir) cells containing c-Fos in rats with fundic distension (n = 7), corpus/antrum distension (n = 7), or sham distension (n = 4). Data are means ± SE. *Significant difference from control group as determined by 1-way ANOVA followed by Fisher's post hoc test. No significant differences were found between fundus- and corpus-distended rats.

 


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
The present study points to a role of central preproglucagon neurons as mediators of meal-related stimuli emanating from the gut. We show that by selectively engaging vagal mechanoreceptors located predominantly in the proximal and distal stomach, c-Fos expression is induced in NTS neurons, including a significant percentage of preproglucagon (GLP-2 positive) neurons. Additionally, the data show gastric distension-induced c-Fos induction in a small fraction of TH-ir neurons in the NTS. The degree of activation of TH-containing neurons is in line with previous work (45), but due to one outlier in the control group, this activation failed to reach statistical significance.

The aim of our study was to elucidate the specific role of the gastric phase of meal ingestion on activity of medullary GLP-1/2 neurons. Whereas normal ingestion of a meal activates many additional neural and humoral sensory systems, including signals from the oral cavity, the small intestine, and postabsorptive sites, balloon distension is a method to selectively activate gastric mechanoreceptors. Notably, to reflect the gastric distension associated with the ingestion of a large meal, the balloon was inflated to mimic the normal fill pattern of rats given a liquid diet after an overnight fast (9). Several studies have examined the pattern of c-Fos expression in the NTS after gastric distension, and it has been shown that c-Fos expression increases with both volume and the rate of distension (pressure) (6, 43, 45). This is in line with electrophysiological recordings from the afferent vagus nerve, showing a dose-dependent relationship between firing rate and gastric volume (31, 32). Additionally, it has been demonstrated that the load-sensitive gastric vagal afferents encode volume rather than nutrients (20), in line with conclusions from behavioral experiments examining appetite-suppressive feedback signals arising from the stomach (26).

The importance of vagal mechanoreceptors in short-term satiety was recently examined in neurotrophin-4 (NT-4)-deficient mice (8). NT-4 knockout mice display a selective loss of one class of vagal mechanoreceptor, the intraganglionic laminar ending (IGLE), whereas the other class of mechanoreceptor, the intramuscular array, remains intact (8). IGLE-deficient mice have longer and larger meals, suggesting a role for IGLEs in short-term satiety, probably by conveying distension feedback to the NTS (8).

Interestingly, the GLP-1 receptor-null mutant mouse also displays mild disturbances in short-term satiety (34). Initial characterization of the GLP-1 receptor knockout mouse questioned the role of GLP-1 in appetite regulation due to the lack of an obese pheno-type (33). However, closer examination of the data presented by Scrocchi et al. (34), shows that indeed the GLP-1 receptor knockout mice display a disturbed satiety sequence by terminating their initial feeding period of the dark phase significantly later than that of wild-type controls, resulting in an increase in food intake in the first hours of the dark phase (34). Coupled with our observation of GLP-1/2 neuron activation by gastric distension, it is tempting to speculate that these neurons play a role in mechanoreceptor-mediated short-term satiation. It would be highly interesting to examine gastric distension-induced activation of GLP-1/2 neurons in NT-4-deficient mice.

The induction of c-Fos in GLP-containing neurons by gastric distension demonstrated in the present experiments contrasts with recent data from Rinaman (28), who examined c-Fos expression in GLP-1-ir neurons after the consumption of a large meal. Whereas ingestion of a large liquid meal was unable to induce c-Fos expression in NTS preproglucagon neurons, Rinaman showed that up to 70% of these cells contained c-Fos after the administration of interoceptive stressors (LPS, LiCl, CCK in high doses) (28). Although it is possible that the differences could have been influenced by the immunohistochemical methods used, the completely different nature of the gastric stimulation used in the two studies clearly makes direct comparison difficult. These differences are emphasized by data from a recent study by Emond et al. (6). Using c-Fos immunocytochemistry, Emond et al. (6) showed that a large degree of signal convergence and integration of different meal-related stimuli occur at the level of the NTS. Notably, the same gastric load resulted in a greater induction of c-Fos in the NTS when present alone than when present together with other meal-related stimuli (6). This clear example of integration at the level of the NTS could explain why selective stimulation of mechanoreceptors (present study) and ingestion of a large meal (28) lead to differential activation of GLP-1/2-containing neurons.

Our finding of distension-induced activation of GLP-1/2-containing neurons raises a number of questions regarding the functional role of these neurons in the regulation of food intake. To date, preproglucagon-derived peptides, GLP-1, GLP-2, and oxyntomodulin have all been shown to inhibit food intake when administered intracerebroventricularly to rats (4, 38, 39, 41, 44). Although the specificity of GLP-1-induced anorexia has been questioned by reports showing taste aversion after centrally administered GLP-1 (16, 41, 42), specific (that is nonaversive) appetite suppression by GLP-1 can be elicited by direct injections into the hypothalamic paraventricular nucleus (21) or into the fourth ventricle (16). Furthermore, in monosodium glutamate-treated rats, central GLP-1-induced appetite suppression is eliminated, whereas GLP-1-induced taste aversion is intact (40), suggesting that indeed GLP-1 acts specifically on central appetite-regulating neurocircuits. A firm body of evidence now supports a role of NTS preproglucagon neurons as mediators of the anorexia elicited by visceral malaise. Rinaman (28) has shown that three potent interoceptive stressors (CCK, LiCl, and LPS) all induce c-Fos expression in a large proportion of GLP-1-ir neurons in the NTS, and LiCl-induced suppression of food intake can be partly blocked by prior central administration of GLP-1 receptor antagonists (27, 35), pointing to a functional role of central GLP-1 neurons in LiCl-induced anorexia. In line with these observations, it was recently found that GLP-1 neurons are activated by central oxytocin administration and that GLP-1 receptor blockade diminishes anorectic responses to oxytocin (29). As central blockade of oxytocinergic neural systems have also been implicated in LiCl anorexia (25), these data suggest that GLP-1 neurons are activated by nauseating stimuli tapping into central oxytocinergic neural pathways (29). In light of the literature supporting a role of GLP-1 in mediating the anorexia associated with gastric malaise, it would be interesting to investigate the ability of gastric balloon distension to produce a conditioned taste aversion.

In conclusion, we showed that moderate gastric distension can activate hindbrain GLP-1/2-containing neurons, consistent with a role of central preproglucagon-derived peptides as inhibitors food intake. The tendency for corpus distension to activate more GLP-2-positive neurons than fundus distension further suggests that, even among gastric distension sensors, the capacity to signal to the brain stem can be different.


    DISCLOSURES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
The study was supported by grants from the National Institute for Diabetes and Digestive and Kidney Disease (DK-47348), The Danish Diabetes Association, The Novo Nordisk Foundation, and Fonden til Lægevidenskabens Fremme.


    ACKNOWLEDGMENTS
 
We are grateful to S. Jensen for excellent technical assistance.


    FOOTNOTES
 

Address for reprint requests and other correspondence: N. Vrang, Rheoscience, Glerupvej 2, 2610 Rødovre, Denmark (E-mail: nv{at}rheoscience.com).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 

  1. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 40: 1457–1463, 1992.[Abstract]
  2. Bell GI, Santerre RF, and Mullenbach GT. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302: 716–718, 1983.[Medline]
  3. Berthoud HR, Earle T, Zheng H, Patterson LM, and Phifer C. Food-related gastrointestinal signals activate caudal brainstem neurons expressing both NMDA and AMPA receptors. Brain Res 915: 143–154, 2001.[Web of Science][Medline]
  4. Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, and Bloom SR. Oxyntomodulin inhibits food intake in the rat. Endocrinology 142: 4244–4250, 2001.[Abstract/Free Full Text]
  5. Drucker DJ, Lovshin J, Baggio L, Nian M, Adatia F, Boushey RP, Liu Y, Saleh J, Yusta B, and Scrocchi L. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2. Ann NY Acad Sci 921: 226–232, 2000.[Web of Science][Medline]
  6. Emond M, Schwartz GJ, and Moran TH. Meal-related stimuli differentially induce c-Fos activation in the nucleus of the solitary tract. Am J Physiol Regul Integr Comp Physiol 280: R1315–R1321, 2001.[Abstract/Free Full Text]
  7. Flint A, Raben A, Astrup A, and Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101: 515–520, 1998.[Web of Science][Medline]
  8. Fox EA, Phillips RJ, Baronowsky EA, Byerly MS, Jones S, and Powley TL. Neurotrophin-4 deficient mice have a loss of vagal intraganglionic mechanoreceptors from the small intestine and a disruption of short-term satiety. J Neurosci 21: 8602–8615, 2001.[Abstract/Free Full Text]
  9. Fraser KA, Raizada E, and Davison JS. Oral-pharyngealesophageal and gastric cues contribute to meal-induced c-fos expression. Am J Physiol Regul Integr Comp Physiol 268: R223–R230, 1995.[Abstract/Free Full Text]
  10. Gützwiller JP, Drewe J, Göke B, Schmidt H, Rohrer B, Lareida J, and Beglinger C. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol Regul Integr Comp Physiol 276: R1541–R1544, 1999.[Abstract/Free Full Text]
  11. Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B, and Orskov C. Proglucagon processing in porcine and human pancreas. J Biol Chem 269: 18827–18833, 1994.[Abstract/Free Full Text]
  12. Holst JJ, Orskov C, Nielsen OV, and Schwartz TW. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 211: 169–174, 1987.[Web of Science][Medline]
  13. Jiao Y, Sun Z, Lee T, Fusco FR, Kimble TD, Meade CA, Cuthbertson S, and Reiner A. A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. J Neurosci Methods 93: 149–162, 1999.[Web of Science][Medline]
  14. Jin SL, Han VK, Simmons JG, Towle AC, Lauder JM, and Lund PK. Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 271: 519–532, 1988.[Web of Science][Medline]
  15. Kieffer TJ and Habener JF. The glucagon-like peptides. Endocr Rev 20: 876–913, 1999.[Abstract/Free Full Text]
  16. Kinzig KP, D'Alessio DA, and Seeley RJ. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci 22: 10470–10476, 2002.[Abstract/Free Full Text]
  17. Kreymann B, Williams G, Ghatei MA, and Bloom SR. Glucagon-like peptide-1 7–36: a physiological incretin in man. Lancet 2: 1300–1304, 1987.[Web of Science][Medline]
  18. Larsen P, Tang-Christensen M, Holst J, and Orskov C. Distribution of glucagon-like peptide-1 (GLP-1) and other preproglucagon derived peptides in the rat hypothalamus and brain stem. Neuroscience 77: 257–270, 1997.[Web of Science][Medline]
  19. Larsen PJ, Fledelius C, Knudsen LB, and Tang-Christensen M. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats 1. Diabetes 50: 2530–2539, 2001.[Abstract/Free Full Text]
  20. Mathis C, Moran TH, and Schwartz GJ. Load-sensitive rat gastric vagal afferents encode volume but not gastric nutrients. Am J Physiol Regul Integr Comp Physiol 274: R280–R286, 1998.[Abstract/Free Full Text]
  21. McMahon LR and Wellman PJ. PVN infusion of GLP-1-(7–36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am J Physiol Regul Integr Comp Physiol 274: R23–R29, 1998.[Abstract/Free Full Text]
  22. Merchenthaler I, Lane M, and Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 403: 261–280, 1999.[Web of Science][Medline]
  23. Mojsov S, Weir GC, and Habener JF. Insulinotropin: glucagon-like peptide I (7–37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79: 616–619, 1987.[Web of Science][Medline]
  24. Munch IC, Moller M, Larsen PJ, and Vrang N. Light-induced c-Fos expression in suprachiasmatic nuclei neurons targeting the paraventricular nucleus of the hamster hypothalamus: phase dependence and immunochemical identification. J Comp Neurol 442: 48–62, 2002.[Web of Science][Medline]
  25. Olson BR, Drutarosky MD, Stricker EM, and Verbalis JG. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinology 129: 785–791, 1991.[Abstract/Free Full Text]
  26. Phillips RJ and Powley TL. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol Regul Integr Comp Physiol 271: R766–R769, 1996.[Abstract/Free Full Text]
  27. Rinaman L. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia. Am J Physiol Regul Integr Comp Physiol 277: R1537–R1540, 1999.[Abstract/Free Full Text]
  28. Rinaman L. Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. Am J Physiol Regul Integr Comp Physiol 277: R582–R590, 1999.[Abstract/Free Full Text]
  29. Rinaman L and Rothe EE. GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats. Am J Physiol Regul Integr Comp Physiol 283: R99–R106, 2002.[Abstract/Free Full Text]
  30. Schirra J, Houck P, Wank U, Arnold R, Goke B, and Katschinski M. Effects of glucagon-like peptide-1(7–36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans. Gut 46: 622–631, 2000.[Abstract/Free Full Text]
  31. Schwartz GJ, McHugh PR, and Moran TH. Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol Regul Integr Comp Physiol 265: R872–R876, 1993.[Abstract/Free Full Text]
  32. Schwartz GJ and Moran TH. Sub-diaphragmatic vagal afferent integration of meal-related gastrointestinal signals. Neurosci Biobehav Rev 20: 47–56, 1996.[Web of Science][Medline]
  33. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, and Drucker DJ. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2: 1254–1258, 1996.[Web of Science][Medline]
  34. Scrocchi LA, Hill ME, Saleh J, Perkins B, and Drucker DJ. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes 49: 1552–1560, 2000.[Abstract]
  35. Seeley RJ, Blake K, Rushing PA, Benoit S, Eng J, Woods SC, and D'Alessio D. The role of CNS glucagon-like peptide-1 (7–36) amide receptors in mediating the visceral illness effects of lithium chloride. J Neurosci 20: 1616–1621, 2000.[Abstract/Free Full Text]
  36. Shindler KS and Roth KA. Double immunofluorescent staining using two unconjugated primary antisera raised in the same species. J Histochem Cytochem 44: 1331–1335, 1996.[Abstract]
  37. Swanson LW. Brain Maps: Structure of the Rat Brain. Amsterdam: Elsevier Science, 1998.
  38. Tang-Christensen M, Larsen P, Göke R, Fink-Jensen A, Jessop D, Moller M, and Sheikh S. Central administration of GLP-1-(7–36)amide inhibits food and water intake in rats. Am J Physiol Regul Integr Comp Physiol 271: R848–R856, 1996.[Abstract/Free Full Text]
  39. Tang-Christensen M, Romer J, Larsen PJ, Thulesen J, and Vrang N. The proglucagon derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 6: 802–807, 2000.[Web of Science][Medline]
  40. Tang-Christensen M, Vrang N, and Larsen PJ. Glucagon-like peptide 1(7–36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes 47: 530–537, 1998.[Abstract]
  41. Thiele TE, Seeley RJ, D'Alessio D, Eng J, Bernstein IL, Woods SC, and van Dijk G. Central infusion of glucagon-like peptide-1-(7–36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem. Brain Res 801: 164–170, 1998.[Web of Science][Medline]
  42. Thiele TE, van Dijk G, Campfield LA, Smit FJ, Burn P, Woods SC, Bernstein IL, and Seeley R. Central infusion of GLP-1, but not leptin, produces conditioned taste aversion in rats. Am J Physiol Regul Integr Comp Physiol 272: R726–R730, 1997.[Abstract/Free Full Text]
  43. Traub RJ, Sengupta JN, and Gebhart GF. Differential c-fos expression in the nucleus of the solitary tract and spinal cord following noxious gastric distention in the rat. Neuroscience 74: 873–884, 1996.[Web of Science][Medline]
  44. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CMB, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JPH, Smith DM, Ghatei MA, Herbert J, and Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69–72, 1996.[Medline]
  45. Willing AE and Berthoud HR. Gastric distension-induced c-fos expression in catecholaminergic neurons of rat dorsal vagal complex. Am J Physiol Regul Integr Comp Physiol 272: R59–R67, 1997.[Abstract/Free Full Text]
  46. Woldbye DPD, Greisen MH, Bolwig TG, Larsen PJ, and Mikkelsen JD. Prolonged induction of c-fos in neuropeptide Y- and somatostatin-immunoreactive neurons of the rat dentate gyrus after electroconvulsive stimulation. Brain Res 720: 111–119, 1996.[Web of Science][Medline]
  47. Zander M, Taskiran M, Toft-Nielsen MB, Madsbad S, and Holst JJ. Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes. Diabetes Care 24: 720–725, 2001.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Physiol.Home page
G. M. Holmes, K. N. Browning, M. Tong, E. Qualls-Creekmore, and R. A. Travagli
Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions
J. Physiol., October 1, 2009; 587(19): 4749 - 4759.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
C. Martin, H Han, S. Anton, F. Greenway, and S. Smith
Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial
J Psychopharmacol, September 1, 2009; 23(7): 814 - 825.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Babic, R. L. Townsend, L. M. Patterson, G. M. Sutton, H. Zheng, and H.-R. Berthoud
Phenotype of neurons in the nucleus of the solitary tract that express CCK-induced activation of the ERK signaling pathway
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R845 - R854.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
P. J Larsen
Mechanisms behind GLP-1 induced weight loss
The British Journal of Diabetes & Vascular Disease, November 1, 2008; 8(2_suppl): S34 - S41.
[Abstract] [PDF]


Home page
DiabetesHome page
D. A. Sandoval, D. Bagnol, S. C. Woods, D. A. D'Alessio, and R. J. Seeley
Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake
Diabetes, August 1, 2008; 57(8): 2046 - 2054.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Faipoux, D. Tome, S. Gougis, N. Darcel, and G. Fromentin
Proteins Activate Satiety-Related Neuronal Pathways in the Brainstem and Hypothalamus of Rats
J. Nutr., June 1, 2008; 138(6): 1172 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. J. Holst
The Physiology of Glucagon-like Peptide 1
Physiol Rev, October 1, 2007; 87(4): 1409 - 1439.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Wan, F. H. Coleman, and R. A. Travagli
Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1474 - G1482.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Zheng, L. M. Patterson, C. B. Phifer, and H.-R. Berthoud
Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R247 - R258.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. A. Cupples
Physiological regulation of food intake
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1438 - R1443.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger
Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1695 - R1706.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. K. Badman and J. S. Flier
The Gut and Energy Balance: Visceral Allies in the Obesity Wars
Science, March 25, 2005; 307(5717): 1909 - 1914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Rinaman
Hindbrain contributions to anorexia
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1035 - R1036.
[Full Text] [PDF]


Home page
DiabetesHome page
L. L. Baggio, Q. Huang, T. J. Brown, and D. J. Drucker
A Recombinant Human Glucagon-Like Peptide (GLP)-1-Albumin Protein (Albugon) Mimics Peptidergic Activation of GLP-1 Receptor-Dependent Pathways Coupled With Satiety, Gastrointestinal Motility, and Glucose Homeostasis
Diabetes, September 1, 2004; 53(9): 2492 - 2500.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Mazda, H. Yamamoto, M. Fujimura, and M. Fujimiya
Gastric distension-induced release of 5-HT stimulates c-fos expression in specific brain nuclei via 5-HT3 receptors in conscious rats
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G228 - G235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. A. Cupples
Endo-neuro-endocrine incretin pathways
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R250 - R250.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/2/R470    most recent
00732.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (52)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vrang, N.
Right arrow Articles by Berthoud, H.-R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vrang, N.
Right arrow Articles by Berthoud, H.-R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.